Relugolix-estradiol-norethisterone (also known as relugolix combination therapy or Ryeqo), is the “first of its kind” daily ...

Ryeqo drug is hailed as a ‘potential step-change’ in how endometriosis is treated A new pill designed to transform the ...

Gedeon Richter's drug is the only licensed GnRH antagonist option and, unlike GnRH agonists like Takeda's Prostap ...

Hoorah for some positive women's health news! A new endometriosis pill has been made available on the NHS in England, in what ...

Thousands of Australian women will soon save hundreds – and in some cases, thousands – of dollars a year for fertility, ...

We believe quality journalism should be available to everyone, paid for by those who can afford it. A first-of-its-kind pill for endometriosis has been approved for NHS use, offering hope for people ...

Ryeqo is likely to start being prescribed to patients in Wales within two months, but there will be restrictions on who can ...

The National Health Service (NHS) in England has approved Gedeon Richter’s Ryeqo (relugolix + estradiol + norethisterone), ...

The new pill is the first long-term daily pill licensed to treat the condition, and works by blocking specific hormones that ...

A FIRST-of-its-kind pill designed to transform treatment of agonising endometriosis will be available on the NHS. The condition affects an estimated 1.5 million women in the UK, causing intense ...

But now the NHS England has approved a daily pill that could help manage pain and other symptoms for those living with the ...

The new tablet, known as Ryeqo or relugolix-estradiol-norethisterone, has been approved to treat women of reproductive age ...